vs

Side-by-side financial comparison of Enovis CORP (ENOV) and Rackspace Technology, Inc. (RXT). Click either name above to swap in a different company.

Rackspace Technology, Inc. is the larger business by last-quarter revenue ($682.8M vs $548.9M, roughly 1.2× Enovis CORP). Rackspace Technology, Inc. runs the higher net margin — -4.8% vs -104.1%, a 99.3% gap on every dollar of revenue. On growth, Rackspace Technology, Inc. posted the faster year-over-year revenue change (-0.4% vs -2.2%). Rackspace Technology, Inc. produced more free cash flow last quarter ($56.0M vs $29.1M). Over the past eight quarters, Enovis CORP's revenue compounded faster (9.8% CAGR vs -0.6%).

Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.

Rackspace Technology, Inc. is an American cloud computing company based in San Antonio, Texas. It also has offices in Reston, Virginia, as well as in Australia, Canada, United Kingdom, India, Dubai, Switzerland, the Netherlands, Germany, Singapore, Mexico, Toronto and Hong Kong. Its data centers are located in Amsterdam (Netherlands), Virginia (USA), Chicago (USA), Dallas (USA), London (UK), Frankfurt (Germany), Hong Kong (China), Kansas City (USA), New York City (USA), San Jose (USA), Shangh...

ENOV vs RXT — Head-to-Head

Bigger by revenue
RXT
RXT
1.2× larger
RXT
$682.8M
$548.9M
ENOV
Growing faster (revenue YoY)
RXT
RXT
+1.7% gap
RXT
-0.4%
-2.2%
ENOV
Higher net margin
RXT
RXT
99.3% more per $
RXT
-4.8%
-104.1%
ENOV
More free cash flow
RXT
RXT
$26.9M more FCF
RXT
$56.0M
$29.1M
ENOV
Faster 2-yr revenue CAGR
ENOV
ENOV
Annualised
ENOV
9.8%
-0.6%
RXT

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ENOV
ENOV
RXT
RXT
Revenue
$548.9M
$682.8M
Net Profit
$-571.1M
$-32.7M
Gross Margin
59.9%
17.6%
Operating Margin
-101.7%
-0.5%
Net Margin
-104.1%
-4.8%
Revenue YoY
-2.2%
-0.4%
Net Profit YoY
18.8%
41.6%
EPS (diluted)
$-9.99
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ENOV
ENOV
RXT
RXT
Q4 25
$548.9M
$682.8M
Q3 25
$564.5M
$671.2M
Q2 25
$558.8M
$666.3M
Q1 25
$665.4M
Q4 24
$561.0M
$685.6M
Q3 24
$505.2M
$675.8M
Q2 24
$525.2M
$684.9M
Q1 24
$516.3M
$690.8M
Net Profit
ENOV
ENOV
RXT
RXT
Q4 25
$-571.1M
$-32.7M
Q3 25
$-36.7M
$-67.1M
Q2 25
$-56.0M
$-54.5M
Q1 25
$-71.5M
Q4 24
$-703.2M
$-56.0M
Q3 24
$-31.5M
$-186.6M
Q2 24
$-18.6M
$25.0M
Q1 24
$-72.0M
$-640.6M
Gross Margin
ENOV
ENOV
RXT
RXT
Q4 25
59.9%
17.6%
Q3 25
59.3%
19.4%
Q2 25
59.5%
19.4%
Q1 25
19.1%
Q4 24
54.8%
19.2%
Q3 24
56.7%
20.3%
Q2 24
55.0%
19.2%
Q1 24
57.7%
19.2%
Operating Margin
ENOV
ENOV
RXT
RXT
Q4 25
-101.7%
-0.5%
Q3 25
-3.0%
-5.1%
Q2 25
-8.4%
-3.8%
Q1 25
-5.8%
Q4 24
-118.5%
-4.2%
Q3 24
-6.3%
-25.7%
Q2 24
-8.4%
-7.9%
Q1 24
-6.8%
-94.5%
Net Margin
ENOV
ENOV
RXT
RXT
Q4 25
-104.1%
-4.8%
Q3 25
-6.5%
-10.0%
Q2 25
-10.0%
-8.2%
Q1 25
-10.7%
Q4 24
-125.4%
-8.2%
Q3 24
-6.2%
-27.6%
Q2 24
-3.5%
3.7%
Q1 24
-13.9%
-92.7%
EPS (diluted)
ENOV
ENOV
RXT
RXT
Q4 25
$-9.99
$-0.13
Q3 25
$-0.64
$-0.28
Q2 25
$-0.98
$-0.23
Q1 25
$-0.31
Q4 24
$-12.69
$-0.20
Q3 24
$-0.58
$-0.82
Q2 24
$-0.34
$0.11
Q1 24
$-1.32
$-2.91

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ENOV
ENOV
RXT
RXT
Cash + ST InvestmentsLiquidity on hand
$33.6M
$105.8M
Total DebtLower is stronger
$1.4B
$2.7B
Stockholders' EquityBook value
$2.0B
$-1.2B
Total Assets
$4.4B
$2.8B
Debt / EquityLower = less leverage
0.67×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ENOV
ENOV
RXT
RXT
Q4 25
$33.6M
$105.8M
Q3 25
$44.1M
$99.5M
Q2 25
$38.5M
$103.9M
Q1 25
$128.0M
Q4 24
$48.2M
$144.0M
Q3 24
$35.4M
$157.1M
Q2 24
$35.0M
$190.2M
Q1 24
$66.3M
$282.6M
Total Debt
ENOV
ENOV
RXT
RXT
Q4 25
$1.4B
$2.7B
Q3 25
$1.4B
$2.8B
Q2 25
$1.4B
$2.8B
Q1 25
$2.8B
Q4 24
$1.3B
$2.8B
Q3 24
$1.3B
$2.8B
Q2 24
$1.3B
$2.9B
Q1 24
$1.3B
$3.0B
Stockholders' Equity
ENOV
ENOV
RXT
RXT
Q4 25
$2.0B
$-1.2B
Q3 25
$2.6B
$-1.2B
Q2 25
$2.6B
$-1.1B
Q1 25
$-1.1B
Q4 24
$2.6B
$-1.0B
Q3 24
$3.3B
$-949.7M
Q2 24
$3.3B
$-756.2M
Q1 24
$3.3B
$-787.2M
Total Assets
ENOV
ENOV
RXT
RXT
Q4 25
$4.4B
$2.8B
Q3 25
$5.0B
$2.8B
Q2 25
$4.9B
$2.9B
Q1 25
$3.0B
Q4 24
$4.7B
$3.1B
Q3 24
$5.6B
$3.1B
Q2 24
$5.4B
$3.4B
Q1 24
$5.5B
$3.5B
Debt / Equity
ENOV
ENOV
RXT
RXT
Q4 25
0.67×
Q3 25
0.54×
Q2 25
0.53×
Q1 25
Q4 24
0.52×
Q3 24
0.40×
Q2 24
0.41×
Q1 24
0.40×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ENOV
ENOV
RXT
RXT
Operating Cash FlowLast quarter
$82.6M
$59.7M
Free Cash FlowOCF − Capex
$29.1M
$56.0M
FCF MarginFCF / Revenue
5.3%
8.2%
Capex IntensityCapex / Revenue
9.7%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$22.8M
$90.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ENOV
ENOV
RXT
RXT
Q4 25
$82.6M
$59.7M
Q3 25
$47.8M
$70.7M
Q2 25
$-1.6M
$8.4M
Q1 25
$12.6M
Q4 24
$88.3M
$54.3M
Q3 24
$53.6M
$51.8M
Q2 24
$7.8M
$24.1M
Q1 24
$-36.2M
$-90.3M
Free Cash Flow
ENOV
ENOV
RXT
RXT
Q4 25
$29.1M
$56.0M
Q3 25
$3.4M
$42.7M
Q2 25
$-44.9M
$-12.4M
Q1 25
$4.3M
Q4 24
$35.1M
$34.4M
Q3 24
$2.4M
$27.3M
Q2 24
$-31.6M
$-14.5M
Q1 24
$-73.1M
$-118.4M
FCF Margin
ENOV
ENOV
RXT
RXT
Q4 25
5.3%
8.2%
Q3 25
0.6%
6.4%
Q2 25
-8.0%
-1.9%
Q1 25
0.6%
Q4 24
6.3%
5.0%
Q3 24
0.5%
4.0%
Q2 24
-6.0%
-2.1%
Q1 24
-14.2%
-17.1%
Capex Intensity
ENOV
ENOV
RXT
RXT
Q4 25
9.7%
0.5%
Q3 25
7.9%
4.2%
Q2 25
7.7%
3.1%
Q1 25
1.2%
Q4 24
9.5%
2.9%
Q3 24
10.1%
3.6%
Q2 24
7.5%
5.6%
Q1 24
7.2%
4.1%
Cash Conversion
ENOV
ENOV
RXT
RXT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.96×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ENOV
ENOV

Reconstructive Segment$258.0M47%
Surgical$129.0M23%
Prevention And Recovery$92.6M17%
Other Prevention And Recovery$71.4M13%

RXT
RXT

Public Cloud Services Segment$442.2M65%
Private Cloud Service Segment$240.6M35%

Related Comparisons